🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

💉 Overcoming T-cell inhibition via the PD-1/PD-L1 axis is a critical challenge in CAR-T cell therapy 📝 Our latest publication in Nature Communications unveils how CAR-antigen affinity could pivotally influence T-cell susceptibility to this axis ⬇️

Rufus has cystic fibrosis and needs the life-changing treatment Kaftrio to help him breathe more easily. The NHS has secured permanent access to this treatment for eligible children and adults with cystic fibrosis, now and in the future.

🌻 June 21, our teams support the #CriglerNajjarDay, a world day dedicated to Crigler-Najjar syndrome, a rare genetic liver disease. 💙The opportunity for GENETHON France to look back at the promising international #gene therapy clinical trial. 👉vu.fr/BbKwx

#news 📢FDA expands approval of gene therapy for patients with Duchenne Muscular Dystrophy

Gene therapy for CNS disorders - a Nature Rev Neurosci review article by Jingjing Gao, Ana Griciuc, Jeffrey M. Karp, Rudolph Tanzi & Nitin Joshi 👉nature.com/articles/s4158…

#event Don't miss the Cost Action GenE-Humdi webinars series dedicated to young scientists! On June 25th, Paula Rio Paula Río will present progress and perspectives in in vivo genome editing, registration 👉crisprmedicinenews.com/cmn-webinars/g…

🚨There is just 1 week left to apply to our DAG! 🚨 The group offers EURORDIS expert guidance on all facets of digital health policies and procedures, drawing on members' personal experiences to shape our policies. ⏰ 30 June Learn more: go.eurordis.org/yfuFoK

🖥️ Do you have personal experience of situations impacted by digital health policy? 💭 Do you have ideas on how they could have been improved? 🫵 We want to hear from you! The application window for the EURORDIS DAG has been extended to 15 July. ➡️ go.eurordis.org/yfuFoK

CHMP meeting highlights – June 2024 In its latest meeting, the Committee for Medicinal Products for Human Use (CHMP) recommended several new medicines, including positive opinions for treatments for rare disorders. buff.ly/3WgeUpr

#event 📢Don't miss the SFTCG webinar presented by Thierry Vandendriessche on "Gene Therapy for Hemophilia: the End of the Beginning?" - Friday, 19 July- 14:00 CEST - watch live on YouTube 👉youtube.com/channel/UCaXNM…

#JobAlert ERC funded Post-doctoral position available at Tigem Telethon 👉: tigem.it/newsroom/caree…